Ventripoint to showcase AI-powered cardiac imaging at major European pediatric cardiology meeting

Ventripoint Diagnostics will exhibit its AI-driven cardiac imaging technology, VMS+™, at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology in Italy. The event gathers over 1,000 specialists focused on congenital heart disease (CHD), highlighting Ventripoint's role in advancing echocardiography for lifelong CHD patient care. VMS+™ offers MRI-level accuracy in cardiac volume measurement, streamlining clinical workflows and supporting better patient management. Ventripoint aims to integrate VMS+™ more widely into routine practice throughout 2026.